A Synchronous Pancreatic Metastasis from Renal Clear Cell Carcinoma, with Unusual CT Characteristics, Completely Regressed after Therapy with Sunitinib
We present a case report of a 75-years-old woman affected by renal clear cell carcinoma with a synchronous pancreatic metastasis and a metachronous lung metastasis. This case has two peculiarities. First the pancreatic metastasis was treated just with medical therapy, that is, Sunitinib, instead of...
Saved in:
| Main Authors: | Salvatore Lauro, Elisa Concetta Onesti, Riccardo Righini, Francesco Carbonetti, Antonio Cremona, Paolo Marchetti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2014/473431 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Kinomic profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma
by: Jeannette C. Oosterwijk-Wakka, et al.
Published: (2025-02-01) -
The predictive value of radiomics and deep learning for synchronous distant metastasis in clear cell renal cell carcinoma
by: Wan-Bin He, et al.
Published: (2025-01-01) -
Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib
by: Ricardo Costa, et al.
Published: (2014-01-01) -
Guillain-Barré Syndrome following Treatment with Sunitinib Malate
by: Ziad Kanaan, et al.
Published: (2014-01-01) -
Genome-wide CRISPR/Cas9 screening identifies PTGR2 as a potential therapeutic target for sunitinib resistance in clear cell renal cell carcinoma
by: Wei Chang, et al.
Published: (2025-07-01)